HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Canada cosmetics labeling guide

This article was originally published in The Rose Sheet

Executive Summary

Canadian regulatory authorities publish a guide to cosmetic ingredient labeling, announced June 22. Available on Health Canada's Web site, guide is intended to clarify what Canadian law requires of companies, providing examples of correct ingredient labels and tips to verify proper International Nomenclature of Cosmetic Ingredients (INCI) labeling. Specific instructions are offered for testers, hotel amenities and other small containers. Guide also specifies how to identify parfum and fragrance, among other points. Health Canada amended its regulations in 2006 to require full INCI names on cosmetics packaging (1"The Rose Sheet" Nov. 13, 2006)

You may also be interested in...



Canadian Cosmetic Ingredient Labeling Effective Nov. 16

Cosmetics manufacturers selling products in Canada will need to comply with the country's new ingredient labeling rules by Nov. 16, the day the requirements come into force

Chinese Firms Up Their Game In Novel Flu Antiviral Development

Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.

Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016244

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel